Society for Research on Nicotine and Tobacco as an Outgrowth of the 1988 Surgeon General's Report on Nicotine Addiction: Reflections of the Early Presidents
- PMID: 37584666
- PMCID: PMC10803119
- DOI: 10.1093/ntr/ntad151
Society for Research on Nicotine and Tobacco as an Outgrowth of the 1988 Surgeon General's Report on Nicotine Addiction: Reflections of the Early Presidents
Abstract
Introduction: The Society for Research on Nicotine and Tobacco began in the United States as a scientific organization "to stimulate the generation and dissemination of new knowledge concerning nicotine and tobacco in all its manifestations." Now in its 30th year, the Society is taking on new challenges in tobacco control, nicotine vaping, product regulation, and public policy.
Aims and methods: This Review describes the formative years of the Society from the perspective of researchers who were in leadership positions during that time, documenting how biobehavioral and clinical research in the first 10 years was a continuation of the scientific mission of the 1988 United States Surgeon General's Report on Nicotine Addiction and summarizing organizational innovations during each president's term of office.
Conclusions: The Society's promotion of scientific research served as a catalyst for funding, policy, and regulation, setting the stage for its influence and credibility.
Implications: This Commentary provides context and an overview of the scientific research and the organizational innovations that occurred during the early years of the Society for Research on Nicotine and Tobacco using publications and available documentation. The Society was able to thrive because biobehavioral research on nicotine addiction provided the scientific underpinnings for the tobacco control enterprise as a whole. The objective of this Commentary is to describe formative events in the Society's history based on the accomplishments of its early leaders.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Ovide F. Pomerleau. No conflicts of interest. Neal L. Benowitz. Dr. Benowitz has been a consultant to pharmaceutical companies that market or are developing smoking-cessation medications, and has been an expert witness in litigation against tobacco companies. Maxine L. Stitzer. Dr. Stitzer has served as a consultant to PEAR Therapeutics and DynamiCare Health, two companies that have developed and marketed phone apps for delivery of substance abuse treatment. Jack E. Henningfield. Jack Henningfield is an employee of PinneyAssociates, Inc. which provides scientific and regulatory consulting support for new drug applications for CNS-active drug products including psychedelic substances, new chemical entities, alternative formulations, as well as dietary ingredient notifications, and cannabinoid assessment. In addition, PinneyAssociates provides consulting services to advance tobacco harm reduction on an exclusive basis for JUUL Labs, Inc. Dr Henningfield also provides expert witness testimony on behalf of JUUL. Dr. Henningfield received no financial support for writing this article and no external commercial interests had any input. Dorothy K. Hatsukami. No conflicts of interest. William A. Corrigall. No conflicts of interest. Kenneth A. Perkins. No conflicts of interests. Harry A. Lando. No conflicts of interests.
Figures
Similar articles
-
A critique of the US Surgeon General's conclusions regarding e-cigarette use among youth and young adults in the United States of America.Harm Reduct J. 2017 Sep 6;14(1):61. doi: 10.1186/s12954-017-0187-5. Harm Reduct J. 2017. PMID: 28874159 Free PMC article. Review.
-
The 1988 US Surgeon General's report Nicotine Addiction: how well has it stood up to three more decades of research?Addiction. 2022 Aug;117(8):2346-2350. doi: 10.1111/add.15754. Epub 2021 Dec 8. Addiction. 2022. PMID: 34817099 No abstract available.
-
Public Health Policies on E-Cigarettes.Curr Cardiol Rep. 2019 Aug 28;21(10):111. doi: 10.1007/s11886-019-1204-y. Curr Cardiol Rep. 2019. PMID: 31463564 Free PMC article. Review.
-
The role of nicotine in tobacco use.Psychopharmacology (Berl). 1992;108(4):397-407. doi: 10.1007/BF02247412. Psychopharmacology (Berl). 1992. PMID: 1410152 Review.
-
Meanings & motives. Experts debating tobacco addiction.Am J Public Health. 2008 Oct;98(10):1793-802. doi: 10.2105/AJPH.2007.114124. Epub 2008 Aug 13. Am J Public Health. 2008. PMID: 18703459 Free PMC article.
References
-
- Pomerleau OF, Hughes JR.. With a little help from its friends: a brief history of the Society for Research on Nicotine and Tobacco (Commentary). Nicotine Tob Res. 2004;6(3):391–395.
-
- The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General, Davis RM, (Senior Editor), Novotny TE and Lynn WR (Managing Editors). Center for Health Promotion and Education, Office on Smoking and Health, United States Public Health Service, Office of the Surgeon General; 1988:1-639. https://profiles.nlm.nih.gov/spotlight/nn/catalog/nlm:nlmuid-101584932X4...
-
- United States Department of Health and Human Services. The health consequences of using smokeless tobacco. A report of the Advisory Committee to the Surgeon General, United States Public Health Service (NIH Publication No. 86-287A). 1986: p viii. Washington DC: U.S. Government Printing Office.
-
- Food and Drug Administration. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco products to protect children and adolescents; proposed rule analysis regarding FDA’s jurisdiction over nicotine-containing cigarettes and smokeless tobacco products; notice. Fed Regist. 1995;60:41314–41792.
-
- Food and Drug Administration. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents; final rule. Fed Regist. 1996;61:44396–45318. - PubMed